"IBD Clinic Pharmacists Help Monitor Complex Drug Regimens"
Incorporating a pharmacist into the workings of an inflammatory bowel disease clinic can help with monitoring of patients and their medications, freeing up gastroenterologists to perform other health care duties, researchers in the United Kingdom have found. The study provides “a perfect example of how clinical pharmacists can be used to the top of our license,” said Stacy S. Tse, PharmD, BCPS, a clinical pharmacist with the Susan and Leonard Feinstein IBD Clinical Center at Mount Sinai. Pharmacists are expanding from a traditional role of medication order verification, Dr. Tse said. “Our specialized training really allows us to optimize medication use, so what they did is exactly what would be the perfect clinic for a pharmacist.” Dr. Tse has helped physicians at the hospital expand the portfolio of services offered, said Marla Dubinsky, MD, the co-director of the Susan and Leonard Feinstein IBD Clinical Center at Mount Sinai.
- Stacey S. Tse, PharmD, BCPS, Clinical Pharmacist, The Susan and Leonard Feinstein IBD Clinical Center at Mount Sinai
- Marla C. Dubinsky, MD, Professor, Pediatrics, Gastroenterology, Icahn School of Medicine at Mount Sinai, Chief, Pediatric Gastroenterology and Hepatology, Kravis Children’s Hospital at Mount Sinai, Co-Director, The Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center, Mount Sinai Hospital